Table 1 Patient characteristics distributed by AKAP13 status

Total

38

28

Median age at surgery

Years (range)

64 (38–85)

61(37–82)

0.211^£

WHO type carcinoma

IDC

33

86.8

23

82.1

0.246*

ILC

4

10.5

4

14.3

IDC + DCIS

1

2.6

0

0.0

Unknown

0

0.0

1

3.6

Tumor diameter

<= 20 mm

20

52.6

14

50.0

1.000

>20 mm

18

47.4

14

50.0

Lymph node status

Negative

29

76.3

14

50.0

0.033

Positive

8

21.1

13

46.4

Unknown

1

2.6

1

3.6

Histological grade ^a

Grade I

9

23.7

12

42.9

0.374*

Grade II

19

50.0

7

25.0

Grade III

10

26.3

8

28.6

Unknown

0

0.0

1

3.6

Estrogen receptor

Low (≥10 % < 75 %)

7

18.4

10

35.7

0.160

High (≥75 %)

30

78.9

18

64.3

Unknown

1

2.6

0

0.0

Progesterone receptor

Negative

11

28.9

15

53.6

0.074

Positive

26

68.4

13

46.4

Unknown

1

2.6

0

0.0

HER2 status

Negative

30

78.9

27

96.4

0.366

Positive

4

10.5

1

3.6

Unknown

4

10.5

0

0.0

ER305phosporylation

Negative

25

78.1

18

66.7

0.510

Positive

5

15.6

6

22.2

Unknown

2

6.3

3

11.1